JP2001517655A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517655A5 JP2001517655A5 JP2000512813A JP2000512813A JP2001517655A5 JP 2001517655 A5 JP2001517655 A5 JP 2001517655A5 JP 2000512813 A JP2000512813 A JP 2000512813A JP 2000512813 A JP2000512813 A JP 2000512813A JP 2001517655 A5 JP2001517655 A5 JP 2001517655A5
- Authority
- JP
- Japan
- Prior art keywords
- defined above
- embedded image
- general formula
- compound
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 6
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 0 *C(*)(CC1(*)*)Cc2c1c(*)c(C=O)c(*)n2 Chemical compound *C(*)(CC1(*)*)Cc2c1c(*)c(C=O)c(*)n2 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012025 fluorinating agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19741399A DE19741399A1 (de) | 1997-09-19 | 1997-09-19 | Tetrahydrochinoline |
| DE19741399.4 | 1997-09-19 | ||
| PCT/EP1998/005658 WO1999015504A1 (de) | 1997-09-19 | 1998-09-07 | 4-phenyltetrahydrochinoline als hemmer des cholesterolestertransferproteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001517655A JP2001517655A (ja) | 2001-10-09 |
| JP2001517655A5 true JP2001517655A5 (enExample) | 2006-01-05 |
Family
ID=7842954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000512813A Pending JP2001517655A (ja) | 1997-09-19 | 1998-09-07 | コレステロールエステル輸送タンパク質のインヒビターとして利用される４−フェニルテトラヒドロキノリン |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6291477B1 (enExample) |
| EP (1) | EP1017677A1 (enExample) |
| JP (1) | JP2001517655A (enExample) |
| AU (1) | AU9537098A (enExample) |
| DE (1) | DE19741399A1 (enExample) |
| WO (1) | WO1999015504A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19741399A1 (de) * | 1997-09-19 | 1999-03-25 | Bayer Ag | Tetrahydrochinoline |
| JPH11185506A (ja) * | 1997-12-24 | 1999-07-09 | Koito Mfg Co Ltd | 車輌用前照灯 |
| EP1115695B1 (en) * | 1998-09-25 | 2005-06-01 | Monsanto Company | (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| JP2005500314A (ja) * | 2001-06-21 | 2005-01-06 | ファイザー・プロダクツ・インク | コレステロールエステル転送蛋白インヒビターの自己乳化性製剤 |
| WO2003000235A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| CZ20033456A3 (en) | 2001-06-22 | 2004-07-14 | Pfizer Products Inc. | Pharmaceutical compositions comprising adsorbates of amorphous drug |
| DE10148436A1 (de) * | 2001-10-01 | 2003-04-17 | Bayer Ag | Tetrahydrochinoline |
| MXPA04005864A (es) | 2001-12-19 | 2004-10-29 | Atherogenics Inc | Derivados de charcona y su uso para tratar enfermedades. |
| WO2003053359A2 (en) | 2001-12-19 | 2003-07-03 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| ATE395044T1 (de) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| JP2006513186A (ja) | 2002-12-20 | 2006-04-20 | ファイザー・プロダクツ・インク | Ｃｅｔｐ阻害剤およびｈｍｇ−ｃｏａレダクターゼ阻害剤を含む剤形 |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| MXPA06001417A (es) * | 2003-08-04 | 2006-05-15 | Pfizer Prod Inc | Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas. |
| KR20060080214A (ko) | 2003-09-26 | 2006-07-07 | 니뽄 다바코 산교 가부시키가이샤 | 잔여 리포프로테인 생산 저해 방법 |
| WO2006065842A2 (en) * | 2004-12-13 | 2006-06-22 | Synta Pharmaceuticals Corp. | 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof |
| AU2005324127A1 (en) * | 2004-12-18 | 2006-07-13 | Bayer Healthcare Ag | (5S) -3-[(S)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as CETP inhibitors |
| US8124775B2 (en) * | 2004-12-18 | 2012-02-28 | Bayer Pharma Aktiengesellschaft | Chemical compound and its use |
| US8617604B2 (en) | 2005-02-03 | 2013-12-31 | Bend Research, Inc. | Pharmaceutical compositions with enhanced performance |
| WO2006098394A1 (ja) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | 脂質吸収抑制方法および脂質吸収抑制剤 |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| DE102006012548A1 (de) | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
| WO2010075069A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| RU2572606C2 (ru) | 2010-07-09 | 2016-01-20 | Дайити Санкио Компани, Лимитед | Замещенное пиридиновое соединение |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| TWI570118B (zh) * | 2012-01-06 | 2017-02-11 | 第一三共股份有限公司 | 經取代之吡啶化合物的酸加成鹽 |
| US9126906B2 (en) * | 2012-02-21 | 2015-09-08 | Celgene Corporation | Asymmetric synthetic processes for the preparation of aminosulfone compounds |
| CA2873295A1 (en) * | 2012-08-24 | 2014-02-27 | F. Hoffmann-La Roche Ag | New bicyclicpyridine derivatives |
| DE102013223272A1 (de) * | 2013-11-14 | 2015-05-21 | Bombardier Transportation Gmbh | Verfahren zur Herstellung eines rohrförmigen Ausstattungselements für ein Schienenfahrzeug |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| US5506219A (en) | 1988-08-29 | 1996-04-09 | E. R. Squibb & Sons, Inc. | Pyridine anchors for HMG-CoA reductase inhibitors |
| ZA911046B (en) | 1990-02-26 | 1992-10-28 | Squibb & Sons Inc | Quinoline and pyridine anchors for hmg-coa reductase inhibitors |
| DE19627419A1 (de) | 1996-07-08 | 1998-01-15 | Bayer Ag | Cycloalkano-pyridine |
| HRP970330B1 (en) | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
| US6207671B1 (en) * | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
| DE19707199A1 (de) | 1997-02-24 | 1998-08-27 | Bayer Ag | Neues Verfahren zur Herstellung von Cycloalkanopyridinen |
| DE19709125A1 (de) | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
| DE19741399A1 (de) * | 1997-09-19 | 1999-03-25 | Bayer Ag | Tetrahydrochinoline |
-
1997
- 1997-09-19 DE DE19741399A patent/DE19741399A1/de not_active Withdrawn
-
1998
- 1998-09-07 JP JP2000512813A patent/JP2001517655A/ja active Pending
- 1998-09-07 US US09/508,483 patent/US6291477B1/en not_active Expired - Fee Related
- 1998-09-07 WO PCT/EP1998/005658 patent/WO1999015504A1/de not_active Ceased
- 1998-09-07 AU AU95370/98A patent/AU9537098A/en not_active Abandoned
- 1998-09-07 EP EP98948921A patent/EP1017677A1/de not_active Withdrawn
-
2001
- 2001-06-04 US US09/873,460 patent/US20020042515A1/en not_active Abandoned
-
2002
- 2002-04-15 US US10/122,546 patent/US6562976B2/en not_active Expired - Fee Related
-
2003
- 2003-03-31 US US10/403,575 patent/US6897317B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001517655A5 (enExample) | ||
| JP2001516757A5 (enExample) | ||
| RU2222534C2 (ru) | Замещенные имидазолы, способ их получения, фармацевтическая композиция на их основе, способы лечения цитокин-опосредованных заболеваний | |
| JP2006524225A5 (enExample) | ||
| RU2000128658A (ru) | Тиенилазолилалкоксиэтанамны, их производные и их применение в качестве лекарственных средств | |
| JP2002513793A5 (enExample) | ||
| KR920021535A (ko) | 다환 아민 화합물 및 그의 거울상 이성질체, 그의 제조방법 및 이를 함유하는 제약학적 조성물 | |
| RU98119523A (ru) | Соединения пиперазина и пиперидина | |
| JP2001519410A5 (enExample) | ||
| JP2003506347A5 (enExample) | ||
| KR840003636A (ko) | 약리학적으로 활성인 피라졸로/4,3-c/피리딘 제조방법 | |
| JP2003509349A5 (enExample) | ||
| JP2007530525A5 (enExample) | ||
| HK1038865A1 (zh) | RAS-法呢基转移酶抑制物与硫丁基醚-7-β-环糊精或2-羟基丙基-β-环糊精的复合物及方法 | |
| JP2004500347A5 (enExample) | ||
| WO2002009715A3 (en) | Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer | |
| JP2005536519A5 (enExample) | ||
| JP2001518459A5 (enExample) | ||
| JP2003511372A5 (enExample) | ||
| DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| JP2004051592A5 (enExample) | ||
| JP2003513075A5 (enExample) | ||
| RU2004117595A (ru) | Производные пиридина в качестве лигандов рецептора nmda | |
| JP2003513066A5 (enExample) | ||
| JP2006519807A5 (enExample) |